PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A polyherbal formula containing P. nigra and Rosmarinus officinalis extracts exhibited antioxidant activity (50-85% scavenging at 1-10 mg/mL) and inhibited rat paw edema in vivo [PMID:35215227].
P. nigra extract exhibited inhibitory activity on the viability, migration, and invasion of NCI-H292 lung cancer cells in vitro [PMID:34866109].
Extracts of P. nigra buds showed a growth inhibitory effect against Staphylococcus aureus and Candida albicans [PMID:33919265].
Evidence summary
PubMed sources
- 1.PMID: 39224767 (2024) — The genome sequence of black poplar, Populus nigra subsp. betulifolia L., 1753 (Salicaceae). · Wellcome open research
- 2.PMID: 36980198 (2023) — Black Poplar (Populus nigra L.) Root Extracellular Trap, Structural and Molecular Remodeling in Response to Osmotic Stress. · Cells
- 3.PMID: 35215227 (2022) — Antioxidant-Anti-Inflammatory Evaluation of a Polyherbal Formula. · Pharmaceuticals (Basel, Switzerland)
- 4.PMID: 35160773 (2022) — Temperature, Time, and Interactions between Them in Relation to Colour Parameters of Black Poplar (Populus nigra L.) Thermally Modified in Nitrogen Atmosphere. · Materials (Basel, Switzerland)
- 5.PMID: 37784104 (2023)